Picture of Kainos Laboratories logo

4556 Kainos Laboratories Cashflow Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMicro CapNeutral

Annual cashflow statement for Kainos Laboratories, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

2022
March 31st
2023
March 31st
2024
March 31st
2025
March 31st
2026
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoTanshin
Standards:
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line767845930827634
Depreciation
Non-Cash Items12.410.91.5316.2115
Unusual Items
Other Non-Cash Items
Changes in Working Capital-325-453-620-242-298
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Other Operating Cash Flow
Cash from Operating Activities604545431705554
Capital Expenditures-141-7.7-75.7-76.9-7.74
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.017-2.632.885.63-19.6
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-141-10.3-72.8-71.3-27.4
Financing Cash Flow Items-0.001-0.001-0.001
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-31.3-191-204-411-182
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash433343154222344